1. A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma. Issue 3 (31st January 2022) Authors: Damato, Anna R; Katumba, Ruth G N; Luo, Jingqin; Atluri, Himachandana; Talcott, Grayson R; Govindan, Ashwin; Slat, Emily A; Weilbaecher, Katherine N; Tao, Yu; Huang, Jiayi; Butt, Omar H; Ansstas, George; Johanns, Tanner M; Chheda, Milan G; Herzog, Erik D; Rubin, Joshua B; Campian, Jian L Journal: Neuro-oncology practice Issue: Volume 9:Issue 3(2022) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study. Issue 1 (2nd March 2021) Authors: Damato, Anna R; Luo, Jingqin; Katumba, Ruth G N; Talcott, Grayson R; Rubin, Joshua B; Herzog, Erik D; Campian, Jian L Journal: Neuro-oncology advances Issue: Volume 3:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗